GILEAD SCIENCES INC's ticker is and the CUSIP is 375558AP8. A total of 62 filers reported holding GILEAD SCIENCES INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,209,800,000 | -12.7% | 1,023 | -4.7% | 1.14% | -12.6% |
| Q4 2015 | $4,822,213,000 | +1.4% | 1,074 | -2.1% | 1.30% | +3.5% |
| Q3 2015 | $4,756,428,000 | -18.4% | 1,097 | -2.8% | 1.26% | -11.0% |
| Q2 2015 | $5,828,018,000 | +11.0% | 1,129 | -7.0% | 1.41% | +92.4% |
| Q1 2015 | $5,249,010,000 | -8.4% | 1,214 | -12.1% | 0.74% | -10.1% |
| Q4 2014 | $5,731,987,000 | -14.9% | 1,381 | -3.8% | 0.82% | -17.9% |
| Q3 2014 | $6,734,224,000 | +20.2% | 1,436 | -99.9% | 1.00% | +15.4% |
| Q2 2014 | $5,604,800,000 | +10.7% | 1,534,000 | +94591.4% | 0.86% | +5.9% |
| Q1 2014 | $5,064,560,000 | -6.0% | 1,620 | -0.6% | 0.82% | -8.6% |
| Q4 2013 | $5,390,583,000 | +14.1% | 1,630 | -4.2% | 0.89% | +0.3% |
| Q3 2013 | $4,725,210,000 | +14.1% | 1,701 | -6.5% | 0.89% | +9.6% |
| Q2 2013 | $4,141,510,000 | – | 1,819 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INCOME RESEARCH & MANAGEMENT | 9,376,000 | $40,393,000 | 6.90% |
| MACKAY SHIELDS LLC | 12,148,000 | $52,358,000 | 2.77% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $6,465,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 6,200,000 | $26,710,000 | 2.53% |
| SSI INVESTMENT MANAGEMENT LLC | 4,620,000 | $19,905,000 | 1.88% |
| CNO Financial Group, Inc. | 500,000 | $2,154,000 | 0.91% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 13,789,000 | $59,376,000 | 0.86% |
| Man Investments (CH) AG | 400,000 | $1,724,000 | 0.83% |
| Lombard Odier Asset Management (Europe) Ltd | 2,380,000 | $10,242,000 | 0.80% |
| CQS Cayman LP | 3,750,000 | $16,252,000 | 0.76% |